10 -

10 - Bellmunt J, Trigo J, Calva E, et al. Activity of a multitargeted chemo-switch regimen (sorafenib,gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06) Lancet Oncol. 2010 Apr;11(4):350-7. Epub 2010 Feb 15.